Cereno Scientific announces that equity research company Edison initiates coverage of the company
Cereno Scientific (Nasdaq First North: CRNO B), a company developing innovative treatments for common and rare cardiovascular disease, today announced that equity research company Edison Investment Research has been engaged by Cereno to produce regular, in-depth research on the company. The intention is to raise the visibility of the company and enable investors and stakeholders to develop an improved understanding of the business.Edison's research is read on a free-to-access basis by individuals and institutions across the globe. Edison's coverage of Cereno will be available on the company